These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1739399)

  • 21. Severe Graves' ophthalmopathy in pregnancy.
    Stafford IP; Dildy GA; Miller JM
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1221-3. PubMed ID: 15863589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic nerve involvement in Graves' ophthalmopathy: a case report and review.
    Dunne JW; Edis RH
    Aust N Z J Med; 1985 Apr; 15(2):258-61. PubMed ID: 3861168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graves' ophthalmopathy.
    Barrie WE
    West J Med; 1993 Jun; 158(6):591-5. PubMed ID: 8337853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graves' ophthalmopathy--a clinical review.
    Carter JN
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe Graves' ophthalmopathy accompanied by myasthenia gravis].
    Maeda K; Kume S; Nishio Y; Maeda S; Nishida Y; Suzuki M; Nakaguchi T; Kawabata T; Hashimoto O; Hisanaga T; Kashiwagi A; Yasuda H
    Rinsho Shinkeigaku; 2006 Apr; 46(4):266-9. PubMed ID: 16768093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up of transnasal orbital decompression in severe Graves' ophthalmopathy.
    Michel O; Oberländer N; Neugebauer P; Neugebauer A; Rüssmann W
    Ophthalmology; 2001 Feb; 108(2):400-4. PubMed ID: 11158820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease.
    Fatourechi V; Bartley GB; Garrity JA; Bergstralh EJ; Ebersold MJ; Gorman CA
    Mayo Clin Proc; 1993 Jun; 68(6):552-5. PubMed ID: 8497132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
    Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
    Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    Ambrosio G; Ferrara G; Vitale R; De Marco R
    Doc Ophthalmol; 2003 Mar; 106(2):99-104. PubMed ID: 12678273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Orbital decompression in treatment of endocrine orbitopathy].
    Tveten S; Mohr C; Esser J
    Mund Kiefer Gesichtschir; 1998 May; 2 Suppl 1():S102-6. PubMed ID: 9658833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic orbital decompression for optic neuropathy in thyroid ophthalmopathy.
    Tang IP; Prepageran N; Subrayan V; Tajunisah I
    Med J Malaysia; 2008 Oct; 63(4):337-8. PubMed ID: 19385499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
    Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ophthalmological evaluation in thyroid-associated ophthalmopathy.
    Asman P
    Acta Ophthalmol Scand; 2003 Oct; 81(5):437-48. PubMed ID: 14510789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    De Marco R; Ambrosio G; Ferrara G
    Doc Ophthalmol; 2000 Sep; 101(2):165-77. PubMed ID: 11200548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):678-82. PubMed ID: 3179255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment by rituximab on six Grave's ophthalmopathies resistant to corticosteroids.
    Précausta F; Arsène S; Renoult-Pierre P; Laure B; Crinière L; Pisella PJ
    Ann Endocrinol (Paris); 2017 Feb; 78(1):20-26. PubMed ID: 28185649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE; Lee CP; Muramatsu SK; Weiner JM
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.